Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus

Tamás Szerafin, Nóra Erdei, Tibor Fülöp, Eniko T. Pasztor, István Édes, Akos Koller, Zsolt Bagi

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Based on findings of experimental models of diabetes mellitus (DM) showing increased expression of vascular cyclooxygenase-2 (COX-2), we hypothesized that in patients with DM changes in COX-2-dependent prostaglandin synthesis affect vasomotor responses of coronary arterioles. Arterioles were dissected from the right atrial appendages obtained at the time of cardiac surgery of patient with DM(+) or without documented diabetes DM(-). Isolated arterioles (89±15 μm in diameter) were cannulated and pressurized (at 80 mm Hg), and changes in diameter were measured with video microscopy. After spontaneous tone developed [DM(-): 32±7%; DM(+): 37±5%; P=NS], arteriolar responses to bradykinin were investigated. Dilations to bradykinin (0.1 nmol/L to 1 μmol/L) were significantly (P<0.05) greater in DM(+) than DM(-) patients (10 nmol/L: 77±10% versus 38±14%). In both groups, dilations were similar to the NO-donor, sodium nitroprusside. In arterioles of DM(+), but not those of DM(-), patients' bradykinin-induced dilations were reduced by the nonselective COX inhibitor indomethacin or by the selective COX-2 inhibitor NS-398 (DM(+) at 10 nmol/L: to 20±4% and 29±7%, respectively). Correspondingly, a marked COX-2 immunostaining was detected in coronary arterioles of DM(+), but not in those of DM(-) patients. We conclude that in coronary arterioles of diabetic patients bradykinin induces enhanced COX-2-derived prostaglandin-mediated dilation. These findings are the first to show that in humans diabetes mellitus increases COX-2 expression and dilator prostaglandin synthesis in coronary arterioles, which may serve to increase dilator capacity and maintain adequate perfusion of cardiac tissues.

Original languageEnglish (US)
Pages (from-to)e12-e17
JournalCirculation research
Volume99
Issue number5
DOIs
StatePublished - Sep 1 2006

Fingerprint

Arterioles
Cyclooxygenase 2
Prostaglandins
Dilatation
Diabetes Mellitus
Bradykinin
Atrial Appendage
Video Microscopy
Experimental Diabetes Mellitus
Cyclooxygenase 2 Inhibitors
Nitroprusside
Indomethacin
Thoracic Surgery
Blood Vessels
Theoretical Models
Perfusion
Tissue Donors

Keywords

  • Bradykinin
  • Cyclooxygenase 2
  • Diabetes mellitus
  • Endothelium
  • Human coronary arteriole
  • Prostacyclin

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. / Szerafin, Tamás; Erdei, Nóra; Fülöp, Tibor; Pasztor, Eniko T.; Édes, István; Koller, Akos; Bagi, Zsolt.

In: Circulation research, Vol. 99, No. 5, 01.09.2006, p. e12-e17.

Research output: Contribution to journalArticle

Szerafin, Tamás ; Erdei, Nóra ; Fülöp, Tibor ; Pasztor, Eniko T. ; Édes, István ; Koller, Akos ; Bagi, Zsolt. / Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. In: Circulation research. 2006 ; Vol. 99, No. 5. pp. e12-e17.
@article{7efe0638ca1f4761a9ff8468a94f72ad,
title = "Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus",
abstract = "Based on findings of experimental models of diabetes mellitus (DM) showing increased expression of vascular cyclooxygenase-2 (COX-2), we hypothesized that in patients with DM changes in COX-2-dependent prostaglandin synthesis affect vasomotor responses of coronary arterioles. Arterioles were dissected from the right atrial appendages obtained at the time of cardiac surgery of patient with DM(+) or without documented diabetes DM(-). Isolated arterioles (89±15 μm in diameter) were cannulated and pressurized (at 80 mm Hg), and changes in diameter were measured with video microscopy. After spontaneous tone developed [DM(-): 32±7{\%}; DM(+): 37±5{\%}; P=NS], arteriolar responses to bradykinin were investigated. Dilations to bradykinin (0.1 nmol/L to 1 μmol/L) were significantly (P<0.05) greater in DM(+) than DM(-) patients (10 nmol/L: 77±10{\%} versus 38±14{\%}). In both groups, dilations were similar to the NO-donor, sodium nitroprusside. In arterioles of DM(+), but not those of DM(-), patients' bradykinin-induced dilations were reduced by the nonselective COX inhibitor indomethacin or by the selective COX-2 inhibitor NS-398 (DM(+) at 10 nmol/L: to 20±4{\%} and 29±7{\%}, respectively). Correspondingly, a marked COX-2 immunostaining was detected in coronary arterioles of DM(+), but not in those of DM(-) patients. We conclude that in coronary arterioles of diabetic patients bradykinin induces enhanced COX-2-derived prostaglandin-mediated dilation. These findings are the first to show that in humans diabetes mellitus increases COX-2 expression and dilator prostaglandin synthesis in coronary arterioles, which may serve to increase dilator capacity and maintain adequate perfusion of cardiac tissues.",
keywords = "Bradykinin, Cyclooxygenase 2, Diabetes mellitus, Endothelium, Human coronary arteriole, Prostacyclin",
author = "Tam{\'a}s Szerafin and N{\'o}ra Erdei and Tibor F{\"u}l{\"o}p and Pasztor, {Eniko T.} and Istv{\'a}n {\'E}des and Akos Koller and Zsolt Bagi",
year = "2006",
month = "9",
day = "1",
doi = "10.1161/01.RES.0000241051.83067.62",
language = "English (US)",
volume = "99",
pages = "e12--e17",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus

AU - Szerafin, Tamás

AU - Erdei, Nóra

AU - Fülöp, Tibor

AU - Pasztor, Eniko T.

AU - Édes, István

AU - Koller, Akos

AU - Bagi, Zsolt

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Based on findings of experimental models of diabetes mellitus (DM) showing increased expression of vascular cyclooxygenase-2 (COX-2), we hypothesized that in patients with DM changes in COX-2-dependent prostaglandin synthesis affect vasomotor responses of coronary arterioles. Arterioles were dissected from the right atrial appendages obtained at the time of cardiac surgery of patient with DM(+) or without documented diabetes DM(-). Isolated arterioles (89±15 μm in diameter) were cannulated and pressurized (at 80 mm Hg), and changes in diameter were measured with video microscopy. After spontaneous tone developed [DM(-): 32±7%; DM(+): 37±5%; P=NS], arteriolar responses to bradykinin were investigated. Dilations to bradykinin (0.1 nmol/L to 1 μmol/L) were significantly (P<0.05) greater in DM(+) than DM(-) patients (10 nmol/L: 77±10% versus 38±14%). In both groups, dilations were similar to the NO-donor, sodium nitroprusside. In arterioles of DM(+), but not those of DM(-), patients' bradykinin-induced dilations were reduced by the nonselective COX inhibitor indomethacin or by the selective COX-2 inhibitor NS-398 (DM(+) at 10 nmol/L: to 20±4% and 29±7%, respectively). Correspondingly, a marked COX-2 immunostaining was detected in coronary arterioles of DM(+), but not in those of DM(-) patients. We conclude that in coronary arterioles of diabetic patients bradykinin induces enhanced COX-2-derived prostaglandin-mediated dilation. These findings are the first to show that in humans diabetes mellitus increases COX-2 expression and dilator prostaglandin synthesis in coronary arterioles, which may serve to increase dilator capacity and maintain adequate perfusion of cardiac tissues.

AB - Based on findings of experimental models of diabetes mellitus (DM) showing increased expression of vascular cyclooxygenase-2 (COX-2), we hypothesized that in patients with DM changes in COX-2-dependent prostaglandin synthesis affect vasomotor responses of coronary arterioles. Arterioles were dissected from the right atrial appendages obtained at the time of cardiac surgery of patient with DM(+) or without documented diabetes DM(-). Isolated arterioles (89±15 μm in diameter) were cannulated and pressurized (at 80 mm Hg), and changes in diameter were measured with video microscopy. After spontaneous tone developed [DM(-): 32±7%; DM(+): 37±5%; P=NS], arteriolar responses to bradykinin were investigated. Dilations to bradykinin (0.1 nmol/L to 1 μmol/L) were significantly (P<0.05) greater in DM(+) than DM(-) patients (10 nmol/L: 77±10% versus 38±14%). In both groups, dilations were similar to the NO-donor, sodium nitroprusside. In arterioles of DM(+), but not those of DM(-), patients' bradykinin-induced dilations were reduced by the nonselective COX inhibitor indomethacin or by the selective COX-2 inhibitor NS-398 (DM(+) at 10 nmol/L: to 20±4% and 29±7%, respectively). Correspondingly, a marked COX-2 immunostaining was detected in coronary arterioles of DM(+), but not in those of DM(-) patients. We conclude that in coronary arterioles of diabetic patients bradykinin induces enhanced COX-2-derived prostaglandin-mediated dilation. These findings are the first to show that in humans diabetes mellitus increases COX-2 expression and dilator prostaglandin synthesis in coronary arterioles, which may serve to increase dilator capacity and maintain adequate perfusion of cardiac tissues.

KW - Bradykinin

KW - Cyclooxygenase 2

KW - Diabetes mellitus

KW - Endothelium

KW - Human coronary arteriole

KW - Prostacyclin

UR - http://www.scopus.com/inward/record.url?scp=33748340627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748340627&partnerID=8YFLogxK

U2 - 10.1161/01.RES.0000241051.83067.62

DO - 10.1161/01.RES.0000241051.83067.62

M3 - Article

C2 - 16917094

AN - SCOPUS:33748340627

VL - 99

SP - e12-e17

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 5

ER -